Register for email alerts and news feeds:
This journal | BMJ Group
rss
Postgraduate Medical Journal 2004;80:107-109; doi:10.1136/pmj.2003.006478
Copyright © 2004 The Fellowship of Postgraduate Medicine.
Postgraduate Medical Journal 2004;80:107-109
© 2004 Fellowship of Postgraduate Medicine

ADVERSE DRUG REACTION

Warfarin and celecoxib interaction in the setting of cytochrome P450 (CYP2C9) polymorphism with bleeding complication

H Malhi1, B Atac2, A K Daly3 and S Gupta4

1 Marion Bessin Liver Research Center and Department of Medicine, Albert Einstein College of Medicine, New York, USA
2 Department of Medicine, Albert Einstein College of Medicine, New York, USA
3 Department of Pharmacological Sciences, University of Newcastle Medical School, Newcastle upon Tyne, UK
4 Marion Bessin Liver Research Center and Departments of Medicine and Pathology, Albert Einstein College of Medicine, New York, USA

Correspondence to:
Correspondence to:
Dr Sanjeev Gupta
Albert Einstein College of Medicine, Ullmann Building, Room 625, 1300 Morris Park Avenue, Bronx, New York 10461, USA; sanjvgupta{at}pol.net

ABSTRACT

Drug metabolism may be perturbed by genetically determined differences in the metabolic activity of cytochrome P450 enzymes. The authors encountered extensive bleeding in a patient receiving warfarin for anticoagulation after the introduction of celecoxib, an anti-inflammatory drug. As the CYP2C9 enzyme metabolises these drugs, it was determined whether variant alleles were responsible for altering warfarin handling. Genetic analysis established that the patient was a compound heterozygote with CYP2C9*2 and *3 variant alleles, which exhibit lower drug metabolising capacity and enhance susceptibility to drug toxicity.

Keywords: warfarin; celecoxib; interaction; bleeding; CYP2C9; polymorphism; allele

Abbreviations: bp, base pair; COX, cyclo-oxygenase; INR, international normalised ratio; PCR, polymerase chain reaction


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Fosslien, E. (2005). Cardiovascular Complications of Non-Steroidal Anti-Inflammatory Drugs. Annals of Clinical & Laboratory Science 35: 347-385 [Abstract] [Full Text]  
  • (2004). Cytochrome P450 polymorphisms, celecoxib, and warfarin. Ann Rheum Dis 63: 717-717 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.